The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infections (uUTIs) in adult females and ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has introduced new monthly safety bulletins aimed at making ...

While Cassava is stopping investigations into simufilam in Alzheimer’s disease, the therapy is now being evaluated in ...

Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

Sanofi will commence a Phase I/II trial with its vaccine candidate in the next few days to start generating immunogenicity ...

Character Biosciences has raised $93m in an oversubscribed Series B funding round to expedite the progression of precision ...

MSD has entered an exclusive licence agreement with Hengrui Pharma for the oral small molecule Lp(a) inhibitor, HRS-5346.

The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

Novo Nordisk has acquired the global rights to United Laboratories’ triple-agonist weight-loss and diabetes drug in a deal ...

Alumis and Kaken Pharmaceutical have entered a partnership and licensing agreement for the development of the former’s ...

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on ...

Evolving regulations in sterile manufacturing requires innovation, market knowledge, and investment. How can drug ...